Your browser doesn't support javascript.
Can low-dose radiation therapy reduce the risk of mucormycosis in COVID-19 patients?
Sharma, Daya Nand; Welsh, James; Kumar, Rishabh.
  • Sharma DN; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India.
  • Welsh J; Department of Radiation Oncology, Stritch School of Medicine, Loyola University, Chicago; Department of Radiation Oncology, Edward Hines Jr VA Hospital, Hines, Illinois, USA.
  • Kumar R; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India.
J Cancer Res Ther ; 17(6): 1294-1296, 2021.
Article in English | MEDLINE | ID: covidwho-1597997

Full text: Available Collection: International databases Database: MEDLINE Main subject: Radiation Dosage / Whole-Body Irradiation / COVID-19 / Mucormycosis Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: J Cancer Res Ther Journal subject: Neoplasms / Therapeutics Year: 2021 Document Type: Article Affiliation country: Jcrt.JCRT_2011_21

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Radiation Dosage / Whole-Body Irradiation / COVID-19 / Mucormycosis Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: J Cancer Res Ther Journal subject: Neoplasms / Therapeutics Year: 2021 Document Type: Article Affiliation country: Jcrt.JCRT_2011_21